CN111850061B - A kind of preparation method of Jinggang hydroxylamine A ester compound - Google Patents
A kind of preparation method of Jinggang hydroxylamine A ester compound Download PDFInfo
- Publication number
- CN111850061B CN111850061B CN201910362858.5A CN201910362858A CN111850061B CN 111850061 B CN111850061 B CN 111850061B CN 201910362858 A CN201910362858 A CN 201910362858A CN 111850061 B CN111850061 B CN 111850061B
- Authority
- CN
- China
- Prior art keywords
- hydroxylamine
- jinggang
- preparation
- reaction
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 title claims description 126
- -1 ester compound Chemical class 0.000 title claims description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 124
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims abstract description 66
- 102000004190 Enzymes Human genes 0.000 claims abstract description 27
- 108090000790 Enzymes Proteins 0.000 claims abstract description 27
- 108010048733 Lipozyme Proteins 0.000 claims abstract description 22
- 239000011942 biocatalyst Substances 0.000 claims abstract description 21
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 16
- 239000000243 solution Substances 0.000 claims description 85
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 claims description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical class [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 26
- 239000002808 molecular sieve Substances 0.000 claims description 25
- 238000010828 elution Methods 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 21
- 239000011347 resin Substances 0.000 claims description 20
- 229920005989 resin Polymers 0.000 claims description 20
- 238000001179 sorption measurement Methods 0.000 claims description 20
- 239000007864 aqueous solution Substances 0.000 claims description 17
- 239000012047 saturated solution Substances 0.000 claims description 17
- 238000000926 separation method Methods 0.000 claims description 8
- 230000035484 reaction time Effects 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 230000032050 esterification Effects 0.000 claims description 3
- 238000005886 esterification reaction Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 238000010025 steaming Methods 0.000 claims 1
- 150000002148 esters Chemical class 0.000 abstract description 39
- 108090001060 Lipase Proteins 0.000 abstract description 15
- 239000004367 Lipase Substances 0.000 abstract description 15
- 102000004882 Lipase Human genes 0.000 abstract description 15
- 235000019421 lipase Nutrition 0.000 abstract description 15
- 229940040461 lipase Drugs 0.000 abstract description 14
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 10
- 229930195729 fatty acid Natural products 0.000 abstract description 10
- 239000000194 fatty acid Substances 0.000 abstract description 10
- 150000004665 fatty acids Chemical class 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 4
- 102100021851 Calbindin Human genes 0.000 abstract description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract description 2
- 241000222175 Diutina rugosa Species 0.000 abstract description 2
- 101000898082 Homo sapiens Calbindin Proteins 0.000 abstract description 2
- 102000019280 Pancreatic lipases Human genes 0.000 abstract description 2
- 108050006759 Pancreatic lipases Proteins 0.000 abstract description 2
- 101001021643 Pseudozyma antarctica Lipase B Proteins 0.000 abstract description 2
- 229940116369 pancreatic lipase Drugs 0.000 abstract description 2
- XPHOBMULWMGEBA-UHFFFAOYSA-N Valienamine Natural products NC1C=C(CO)C(O)C(O)C1O XPHOBMULWMGEBA-UHFFFAOYSA-N 0.000 abstract 2
- XPHOBMULWMGEBA-VZFHVOOUSA-N valienamine Chemical compound N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O XPHOBMULWMGEBA-VZFHVOOUSA-N 0.000 abstract 2
- VDLOJRUTNRJDJO-ZYNSJIGGSA-N (1s,2s,3r,4s,5s)-5-amino-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol Chemical compound N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O VDLOJRUTNRJDJO-ZYNSJIGGSA-N 0.000 abstract 1
- GSQYAWMREAXBHF-UHFFFAOYSA-N Validamine Natural products NC1CC(CO)C(O)C(O)C1O GSQYAWMREAXBHF-UHFFFAOYSA-N 0.000 abstract 1
- VDLOJRUTNRJDJO-UHFFFAOYSA-N Valiolamine Natural products NC1CC(O)(CO)C(O)C(O)C1O VDLOJRUTNRJDJO-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- GSQYAWMREAXBHF-UOYQFSTFSA-N validamine Chemical compound N[C@H]1C[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GSQYAWMREAXBHF-UOYQFSTFSA-N 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 54
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 48
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 38
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical group CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 18
- 229910052740 iodine Inorganic materials 0.000 description 18
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 17
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 17
- 239000008367 deionised water Substances 0.000 description 17
- 229910021641 deionized water Inorganic materials 0.000 description 17
- 239000003480 eluent Substances 0.000 description 17
- 239000011630 iodine Substances 0.000 description 17
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 17
- 239000011734 sodium Substances 0.000 description 16
- 150000001875 compounds Chemical class 0.000 description 13
- 238000004128 high performance liquid chromatography Methods 0.000 description 13
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 241000813090 Rhizoctonia solani Species 0.000 description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 6
- WQEPLUUGTLDZJY-UHFFFAOYSA-N pentadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 6
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 5
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
- 229930195482 Validamycin Natural products 0.000 description 3
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 229960002446 octanoic acid Drugs 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 3
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- 241000589291 Acinetobacter Species 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 101150065749 Churc1 gene Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 102100038239 Protein Churchill Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102100029677 Trehalase Human genes 0.000 description 2
- 108010087472 Trehalase Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- PRFJDHVGPGARSU-UHFFFAOYSA-N hydroxylamine;propanoic acid Chemical compound ON.CCC(O)=O PRFJDHVGPGARSU-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- 229940070710 valerate Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- AJOFHOWDXCAUHV-UHFFFAOYSA-N 8,8,8-trichlorooctanoic acid Chemical compound OC(=O)CCCCCCC(Cl)(Cl)Cl AJOFHOWDXCAUHV-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical group OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- MKULCFKXVMCMPO-UHFFFAOYSA-N NO.C(CCC)(=O)O Chemical compound NO.C(CCC)(=O)O MKULCFKXVMCMPO-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
- 241001233605 Streptomyces hygroscopicus subsp. jinggangensis Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- HMNQNULAYXDEEQ-UHFFFAOYSA-N acetic acid;hydroxylamine Chemical compound ON.CC(O)=O HMNQNULAYXDEEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种酶催化制备井冈羟胺A酯化物的方法。The invention relates to an enzyme-catalyzed method for preparing Jinggang hydroxylamine A ester.
背景技术Background technique
井冈霉素(Validamycin)是一种假三糖类化合物,于1970年在吸水链霉菌柠檬变种(Streptomyce hygroscopicus var.lemonesus)的次生代谢产物中分离得到,被命名为有效霉素。1973年上海市农药研究所在江西井冈山以及浙江杭州的土壤中发现并筛选出能够抑制水稻纹枯病(Rhizoctonia solani)的吸水链霉菌井冈变种(S.hygroscopicusvar.jinggangensis)菌株,经研究,从中提取的活性化合物化学结构与有效霉素是一致的,其有效成分被命名为井冈霉素(jinggangmycin)。井冈霉素能高效地抑制水稻纹枯病,对蔬菜幼苗枯萎病也具有一定的杀菌效果,另外具有长久药效,低毒性,低残留,高安全,环境污染小的优势使其成为我国推广使用面积最大、亩用成本最低的无公害生物源农药。Validamycin, a pseudotrisaccharide compound, was isolated in 1970 from the secondary metabolites of Streptomyce hygroscopicus var.lemonesus, and was named validamycin. In 1973, the Shanghai Institute of Pesticides discovered and screened the strain of Streptomyces hygroscopicus var. Jinggangensis (S. hygroscopicus var. jinggangensis) that can inhibit rice sheath blight (Rhizoctonia solani) in the soil of Jinggangshan, Jiangxi and Hangzhou, Zhejiang. After research, it was extracted from it. The chemical structure of the active compound is consistent with validamycin, and its active ingredient is named jinggangmycin. Jinggangmycin can effectively inhibit rice sheath blight, and has a certain bactericidal effect on vegetable seedling wilt. In addition, it has long-term efficacy, low toxicity, low residue, high safety, and low environmental pollution. The advantages make it popular in my country The pollution-free biological source pesticide with the largest area and the lowest cost per mu.
井冈霉素A是井冈霉素类化合物中最重要也是最主要的组分,其分子结构包含井冈羟胺A和一个D型吡喃葡萄糖基,是一类假三糖类化合物。Jinggangmycin A is the most important and main component of Jinggangmycin compounds. Its molecular structure contains Jinggang hydroxylamine A and a D-type glucopyranose group. It is a class of pseudotrisaccharide compounds.
井冈羟胺A化学结构同海藻糖类似(如下所示),被认为是一类具有高活性的天然海藻糖酶竞争性抑制剂,其结构新颖,离体杀菌效果好,选择性强,对海藻糖酶的抑制效果能达到10-8-10-9mol/L,另外其对哺乳动物以及高等植物的安全性高,具有很好的应用前景。The chemical structure of Jinggang Hydroxylamine A is similar to that of trehalose (as shown below), and it is considered to be a kind of competitive inhibitor of natural trehalase with high activity. It has a novel structure, good bactericidal effect in vitro, and strong selectivity. The inhibitory effect of the enzyme can reach 10 -8 -10 -9 mol/L, in addition, it has high safety to mammals and higher plants, and has a good application prospect.
井冈羟胺A具有较强的离体海藻糖酶抑制活性,但很难进入生物体内,因此,有必要通过修饰井冈羟胺A的结构,增加其进入生物体内的能力,以此解决靠“注射”才能发挥其杀虫、杀菌活性的问题,而酯合成则成为了一个首选的方案。但是,井冈羟胺A上羟基数量较多,常规的化学合成法很难精准控制酯化位点,而本发明采用的脂肪酶催化合成法,可准确控制反应位点,并最终得到高纯度的衍生物。进一步对其生物活性进行研究,研究表明,其具有很好的生物活性。Jinggang Hydroxylamine A has a strong trehalase inhibitory activity in vitro, but it is difficult to enter the organism. Therefore, it is necessary to modify the structure of Jinggang Hydroxylamine A to increase its ability to enter the organism, so as to solve the problem that can only be solved by "injection". To exert its insecticidal and bactericidal activity, ester synthesis has become a preferred solution. However, the number of hydroxyl groups on Jinggang hydroxylamine A is relatively large, and it is difficult to accurately control the esterification site by conventional chemical synthesis methods. However, the lipase-catalyzed synthesis method adopted in the present invention can accurately control the reaction sites and finally obtain high-purity derivatives. thing. Further research on its biological activity shows that it has good biological activity.
发明内容Contents of the invention
本发明的目的是提供一种酶催化制备井冈羟胺A酯化物的方法,该方法可准确控制反应位点,得到高纯度的井冈羟胺A酯化物。The object of the present invention is to provide an enzyme-catalyzed method for preparing Jinggang hydroxylamine A ester, which can accurately control the reaction site and obtain high-purity Jinggang hydroxylamine A ester.
为实现上述发明目的,本发明采用如下技术方案:In order to realize the above-mentioned purpose of the invention, the present invention adopts following technical scheme:
一种式(I)所示的井冈羟胺A酯化物的制备方法,所述方法为:井冈羟胺A和脂肪酸RCOOH在叔丁醇中在生物催化剂的作用下反应制得式(I)所示的井冈羟胺A的酯化物;所述生物催化剂为Lipozyme RMIM、Lipase CALB、猪胰脂肪酶、假丝酵母脂肪酶、皱褶假丝酵母脂肪酶中的一种;A preparation method of Jinggang hydroxylamine A esterified product shown in formula (I), described method is: Jinggang hydroxylamine A and fatty acid RCOOH are reacted under the effect of biocatalyst in tert-butanol and prepared formula (I) The esterification of Jinggang hydroxylamine A; the biocatalyst is one of Lipozyme RMIM, Lipase CALB, porcine pancreatic lipase, Candida lipase, and Candida rugosa lipase;
R为C1-C21的饱和脂烃基、C1-C21的不饱和脂烃基或C1-C21的卤代饱和脂烃基。R is a C 1 -C 21 saturated aliphatic group, a C 1 -C 21 unsaturated aliphatic group or a C 1 -C 21 halogenated saturated aliphatic group.
作为优选,R=CnH2n+1,其中n=1-21。进一步优选n=8-18,更进一步优选n=10-18,再更进一步优选10-17。Preferably, R=C n H 2n+1 , where n=1-21. More preferably n=8-18, still more preferably n=10-18, still more preferably 10-17.
作为优选,R=CnH2n-1,其中n=1-21。进一步优选n=3-18,更进一步优选n=5-18,特别优选n=7-18,如R=CH2=CHCH2CH2CH2CH2CH2。Preferably, R=C n H 2n-1 , where n=1-21. More preferably n=3-18, even more preferably n=5-18, especially preferably n=7-18, such as R=CH 2 =CHCH 2 CH 2 CH 2 CH 2 CH 2 .
作为优选,R=CnH2n+1-mXm,其中n=1-21,m≤2n+1,X=F、Cl、Br或I。进一步优选n=3-18,更进一步优选n=5-18,特别优选n=7-18。进一步优选X=Cl。特别优选R=CCl3CH2CH2CH2CH2CH2CH2。Preferably, R=C n H 2n+1-m X m , wherein n=1-21, m≤2n+1, X=F, Cl, Br or I. More preferably n=3-18, even more preferably n=5-18, especially preferably n=7-18. More preferably X=Cl. Particular preference is given to R═CCl 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 .
作为优选,反应体系中还加入经过活化的分子筛,所述分子筛的用量以井冈羟胺A的摩尔数计为0.4-2g/mmoL,更优选为1.2-2.0g/mmoL,最优选为1.2g/mmoL。作为进一步的优选,所述的分子筛为4A°分子筛。作为进一步的优选,所述的分子筛在使用前先进行活化。活化方法推荐为:400℃活化2h。As a preference, an activated molecular sieve is also added to the reaction system, and the amount of the molecular sieve is 0.4-2g/mmoL based on the moles of Jinggang hydroxylamine A, more preferably 1.2-2.0g/mmoL, most preferably 1.2g/mmoL . As a further preference, the molecular sieve is 4A° molecular sieve. As a further preference, the molecular sieve is activated before use. The recommended activation method is: activate at 400°C for 2 hours.
作为优选,所述的生物催化剂是Lipozyme RMIM,此时井冈羟胺A转化率最高。Preferably, the biocatalyst is Lipozyme RMIM, and the conversion rate of Jinggang hydroxylamine A is the highest at this time.
作为优选,所述的投料方式为:使井冈羟胺A在叔丁醇中于90-110℃回流搅拌4-6h制得井冈羟胺A饱和溶液,然后将井冈羟胺A饱和溶液和脂肪酸RCOOH在反应容器中混合。这种投料方式可以显著提高井冈羟胺A在叔丁醇中的溶解度,从而有效提高反应效率。As a preference, the feeding method is: reflux and stir Jinggang hydroxylamine A in tert-butanol at 90-110°C for 4-6h to obtain a saturated solution of Jinggang hydroxylamine A, and then add the saturated solution of Jinggang hydroxylamine A and fatty acid RCOOH to the reaction vessel mix in. This feeding method can significantly increase the solubility of Jinggang hydroxylamine A in tert-butanol, thereby effectively improving the reaction efficiency.
作为进一步的优选,所述制备方法具体按照如下实施:将井冈羟胺A-叔丁醇饱和溶液和脂肪酸RCOOH在反应容器中于25-50℃充分混合,然后加入生物催化剂在25-50℃振荡反应,充分反应后,反应液经分离纯化得到井冈羟胺A的酯化物;所述井冈羟胺A与脂肪酸RCOOH的投料摩尔比为4:1-1:4,所述生物催化剂的用量以井冈羟胺A的摩尔数计为40-240g/moL。As a further preference, the preparation method is specifically implemented as follows: fully mix the Jinggang hydroxylamine A-tert-butanol saturated solution and the fatty acid RCOOH in a reaction vessel at 25-50°C, then add a biocatalyst and shake the reaction at 25-50°C After fully reacting, the reaction solution is separated and purified to obtain the esterified product of Jinggang Hydroxylamine A; The number of moles is 40-240g/moL.
作为更进一步的优选,反应体系中还加入分子筛,所述分子筛的用量以井冈羟胺A的摩尔数计为0.4-2g/mmoL,更优选为1.2-2.0g/mmoL,最优选为1.2g/mmoL。As a further preference, molecular sieves are also added to the reaction system, the amount of molecular sieves is 0.4-2g/mmoL based on the moles of Jinggang hydroxylamine A, more preferably 1.2-2.0g/mmoL, most preferably 1.2g/mmoL .
作为更进一步的优选,所述的生物催化剂是Lipozyme RMIM,此时井冈羟胺A转化率最高。As a further preference, the biocatalyst is Lipozyme RMIM, at this time Jinggang hydroxylamine A conversion rate is the highest.
作为更进一步的优选,所述的生物催化剂是Lipozyme RMIM,所述生物催化剂的用量以井冈羟胺A的摩尔数计为160-240g/moL,最优选为160g/moL。As a further preference, the biocatalyst is Lipozyme RMIM, and the amount of the biocatalyst is 160-240 g/moL, most preferably 160 g/moL, based on the moles of Jinggang Hydroxylamine A.
作为更进一步的优选,所述的生物催化剂是Lipozyme RMIM,反应时间为48h时达到平衡。As a further preference, the biocatalyst is Lipozyme RMIM, and the equilibrium is reached when the reaction time is 48h.
作为更进一步的优选,所述的生物催化剂是Lipozyme RMIM,反应温度为45-50℃,最适温度为45℃。As a further preference, the biocatalyst is Lipozyme RMIM, the reaction temperature is 45-50°C, and the optimum temperature is 45°C.
作为更进一步的优选,所述的生物催化剂是Lipozyme RMIM,所述井冈羟胺A与脂肪酸RCOOH的投料摩尔比为1:2-4,最优选为1:3。As a further preference, the biocatalyst is Lipozyme RMIM, and the molar ratio of Jinggang hydroxylamine A to fatty acid RCOOH is 1:2-4, most preferably 1:3.
本发明最优选生物催化剂是Lipozyme RMIM时的反应条件为:井冈羟胺A与脂肪酸RCOOH的摩尔比为1:3,酶加量为160g/moL井冈羟胺A,分子筛的用量为1.2g/mmoL井冈羟胺A,反应温度为45℃,反应时间为48h。The reaction condition when the most preferred biocatalyst of the present invention is Lipozyme RMIM is: the molar ratio of Jinggang hydroxylamine A and fatty acid RCOOH is 1:3, and the enzyme dosage is 160g/moL Jinggang hydroxylamine A, and the consumption of molecular sieve is 1.2g/mmoL Jinggang hydroxylamine A, the reaction temperature is 45°C, and the reaction time is 48h.
作为更进一步的优选,所述的分离纯化的具体步骤为:离心除去生物催化剂(及分子筛),蒸除溶剂,然后加水并用氢氧化钠调节pH值至中性,通过大孔吸附树脂柱分离,以体积浓度为0%-55%的乙醇水溶液为洗脱试剂进行梯度洗脱,收集目标液,浓缩干燥。As a further preference, the specific steps of the separation and purification are: centrifuging to remove the biocatalyst (and molecular sieve), distilling off the solvent, then adding water and adjusting the pH value to neutral with sodium hydroxide, separating through a macroporous adsorption resin column, Gradient elution is carried out with ethanol aqueous solution with a volume concentration of 0%-55% as the elution reagent, and the target liquid is collected, concentrated and dried.
本发明所述的式(I)所示的井冈羟胺A酯化物对水稻纹枯病具有良好的抑制作用。The Jinggang hydroxylamine A ester represented by the formula (I) of the present invention has a good inhibitory effect on rice sheath blight.
与现有技术相比,本发明的有益效果在于:Compared with prior art, the beneficial effect of the present invention is:
(1)本发明提供了一种提高井冈羟胺A溶解性的方法,可提高井冈羟胺A在叔丁醇中的溶解度。(1) The present invention provides a method for improving the solubility of Jinggang hydroxylamine A, which can improve the solubility of Jinggang hydroxylamine A in tert-butanol.
(2)本发明提供了一种酶催化制备井冈羟胺A酯化物的方法,该方法可准确控制反应位点,得到高纯度的井冈羟胺A酯化物。(2) The present invention provides an enzyme-catalyzed method for preparing Jinggang hydroxylamine A ester, which can accurately control the reaction site and obtain high-purity Jinggang hydroxylamine A ester.
(3)本发明通过加入分子筛可明显提高井冈羟胺A和脂肪酸的反应效率。(3) The present invention can significantly improve the reaction efficiency of Jinggang hydroxylamine A and fatty acid by adding molecular sieves.
具体实施方式detailed description
下面结合具体实施例对本发明进行进一步描述,但本发明的保护范围并不仅限于此。The present invention will be further described below in conjunction with specific examples, but the protection scope of the present invention is not limited thereto.
实施例1:产脂肪酶菌株的发酵Embodiment 1: the fermentation of producing lipase strain
本发明将琼氏不动杆菌zjutfet-1(保藏于中国典型培养物保藏中心,保藏日期为2015年9月6日,保藏编号CCTCC NO.M2015511,保藏地址为中国武汉武汉大学,邮编430072),应用于所述化合物的合成。该菌的培养方法如下文所述:In the present invention, Acinetobacter agarnei zjutfet-1 (preserved in the China Type Culture Collection Center, the preservation date is September 6, 2015, the preservation number CCTCC NO.M2015511, and the preservation address is Wuhan University, Wuhan, China, postcode 430072), Applied to the synthesis of the compound. The culture method of this bacterium is as follows:
将琼氏不动杆菌zjutfet-1接种至斜面培养基,在35℃培养20h,获得斜面菌落;所述斜面培养基终浓度组成为:LB培养基+2%琼脂粉。Inoculate Acinetobacter agarnei zjutfet-1 into the slant medium and culture at 35° C. for 20 hours to obtain slant colonies; the final concentration of the slant medium is composed of: LB medium + 2% agar powder.
将斜面菌落接种于种子培养基,在30℃培养6h,获得种子液,所述种子培养基终浓度组成为蛋白胨10g/L,酵母提取物5g/L,NaCl 10g/L,溶剂为蒸馏水,pH值为7.0;The slant colonies were inoculated on the seed medium, and cultured at 30°C for 6 hours to obtain the seed liquid. The final concentration of the seed medium was composed of peptone 10g/L, yeast extract 5g/L, NaCl 10g/L, the solvent was distilled water, and the pH Value is 7.0;
将种子液以体积浓度0.2%接种量接种于发酵培养基,在30℃、180rpm的条件下培养48h,将发酵液离心,弃上清液,获得湿菌体,随后进行冷冻干燥获得下文所述的菌体冻干粉。所述发酵培养基组成蛋白胨10g/L、蔗糖5g/L、磷酸氢二钾10g/L、硫酸镁0.5g/L,橄榄油50g/L,溶剂为蒸馏水,pH值为7.0。The seed solution was inoculated on the fermentation medium with an inoculum volume concentration of 0.2%, cultivated at 30°C and 180rpm for 48 hours, centrifuged the fermentation solution, discarded the supernatant to obtain wet bacteria, and then freeze-dried to obtain the following freeze-dried powder of bacteria. The fermentation medium consists of peptone 10g/L, sucrose 5g/L, dipotassium hydrogen phosphate 10g/L, magnesium sulfate 0.5g/L, olive oil 50g/L, solvent is distilled water, and the pH value is 7.0.
实施例2:乙酸井冈羟胺A酯(化合物1)的制备(R1=CH3CO-,R2-R8=H):Example 2: Preparation of Hydroxylamine Acetate A (Compound 1) (R 1 =CH 3 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和乙酸(0.120g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱(上海华震科技有限公司,HZ-801)分离,洗脱液为0%-55%的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到0.38g乙酸井冈羟胺A酯,纯度98.8%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1(体积比),显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and acetic acid (0.120g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH = 7, and then pass through a macroporous adsorption resin column (Shanghai Huazhen Technology Co., Ltd. Company, HZ-801) separation, the eluent is 0%-55% ethanol aqueous solution for gradient elution, the target liquid is collected, concentrated and dried to obtain 0.38g Jinggang Hydroxylamine A acetate with a purity of 98.8%. TLC detects the concentrated solution, the developer is n-propanol:water:acetic acid=4:1:1 (volume ratio), and the color developer is iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.58(dd,J=6.2,0.6Hz,1H),4.74(d,J=0.9Hz,2H),4.06(s,1H),3.72(dd,J=2.5,1.5Hz,1H),3.57–3.54(m,1H),3.52(dd,J=12.2,8.0Hz,1H),3.35(t,J=8.3Hz,1H),3.27(dd,J=12.4,8.2Hz,1H),3.17(dd,J=7.9,1.8Hz,1H),3.13–3.11(m,1H),3.09(dd,J=9.2,6.3Hz,1H),2.08(d,J=1.0Hz,1H),2.07(dd,J=6.5,4.1Hz,1H),2.01(s,3H),1.76(s,1H),1.33–1.31(m,1H),1.07–1.05(m,1H).ESI-MS:[M+H]:378.1719. 1 H NMR (600MHz, DMSO) δ5.58(dd, J=6.2,0.6Hz,1H),4.74(d,J=0.9Hz,2H),4.06(s,1H),3.72(dd,J=2.5 ,1.5Hz,1H),3.57–3.54(m,1H),3.52(dd,J=12.2,8.0Hz,1H),3.35(t,J=8.3Hz,1H),3.27(dd,J=12.4, 8.2Hz, 1H), 3.17(dd, J=7.9, 1.8Hz, 1H), 3.13–3.11(m, 1H), 3.09(dd, J=9.2, 6.3Hz, 1H), 2.08(d, J=1.0 Hz,1H),2.07(dd,J=6.5,4.1Hz,1H),2.01(s,3H),1.76(s,1H),1.33–1.31(m,1H),1.07–1.05(m,1H) .ESI-MS:[M+H]:378.1719.
实施例3:丙酸井冈羟胺A酯(化合物2)的制备(R1=CH3CH2CO-,R2-R8=H):Example 3: Preparation of Hydroxylamine Propionate A (Compound 2) (R 1 =CH 3 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和丙酸(0.148g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到丙酸井冈羟胺A酯0.42g,纯度98.5%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and propionic acid (0.148g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol was added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.42 g of Jinggang Hydroxylamine Propionate A with a purity of 98.5%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.58(dd,J=6.2,0.6Hz,1H),4.72(d,J=0.6Hz,2H),4.06(dd,J=4.2,0.7Hz,1H),3.85(dt,J=5.5,3.7Hz,1H),3.70(dd,J=9.4,4.3Hz,1H),3.60(dd,J=9.3,4.2Hz,1H),3.52(dd,J=12.4,7.6Hz,1H),3.27(dd,J=12.4,7.6Hz,1H),3.19–3.14(m,2H),3.09(dd,J=6.2,4.4Hz,1H),2.88–2.81(m,1H),2.48(dd,J=7.5,2.9Hz,1H),2.46–2.42(m,2H),1.68(s,1H),1.37–1.26(m,1H),1.20(t,J=6.8Hz,3H),1.09(dd,J=8.2,3.6Hz,1H). 1 H NMR (600MHz, DMSO) δ5.58(dd, J=6.2,0.6Hz,1H),4.72(d,J=0.6Hz,2H),4.06(dd,J=4.2,0.7Hz,1H), 3.85(dt,J=5.5,3.7Hz,1H),3.70(dd,J=9.4,4.3Hz,1H),3.60(dd,J=9.3,4.2Hz,1H),3.52(dd,J=12.4, 7.6Hz, 1H), 3.27(dd, J=12.4, 7.6Hz, 1H), 3.19–3.14(m, 2H), 3.09(dd, J=6.2, 4.4Hz, 1H), 2.88–2.81(m, 1H ),2.48(dd,J=7.5,2.9Hz,1H),2.46–2.42(m,2H),1.68(s,1H),1.37–1.26(m,1H),1.20(t,J=6.8Hz, 3H), 1.09(dd, J=8.2, 3.6Hz, 1H).
ESI-MS:[M+H]+:392.1867.ESI-MS:[M+H] + :392.1867.
实施例4:丁酸井冈羟胺A酯(化合物3)的制备(R1=CH3CH2CH2CO-,R2-R8=H):Example 4: Preparation of Hydroxylamine Butyrate A (Compound 3) (R 1 =CH 3 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和丁酸(0.176g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到丁酸井冈羟胺A酯0.45g,纯度98.2%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and butyric acid (0.176g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.45 g of Jinggang Hydroxylamine A Butyrate, with a purity of 98.2%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ4.73(d,J=13.9Hz,2H),4.56(s,1H),4.41(dd,J=9.5,5.8Hz,1H),4.31(s,1H),3.77(t,J=8.4Hz,1H),3.53(dd,J=10.4,3.8Hz,1H),3.49–3.41(m,1H),3.41–3.23(m,6H),3.09(t,J=8.7Hz,1H),2.13(dt,J=11.2,6.9Hz,1H),1.89(s,5H),1.87–1.80(m,1H),1.53(ddd,J=14.9,11.7,5.8Hz,1H). 1 H NMR (600MHz, DMSO) δ4.73(d, J=13.9Hz, 2H), 4.56(s, 1H), 4.41(dd, J=9.5, 5.8Hz, 1H), 4.31(s, 1H), 3.77(t,J=8.4Hz,1H),3.53(dd,J=10.4,3.8Hz,1H),3.49–3.41(m,1H),3.41–3.23(m,6H),3.09(t,J= 8.7Hz, 1H), 2.13(dt, J=11.2, 6.9Hz, 1H), 1.89(s, 5H), 1.87–1.80(m, 1H), 1.53(ddd, J=14.9, 11.7, 5.8Hz, 1H ).
ESI-MS[M+H]+406.2067,[M+Na]+428.1890ESI-MS[M+H] + 406.2067,[M+Na] + 428.1890
实施例5:戊酸井冈羟胺A酯(化合物4)的制备(R1=CH3CH2CH2CH2CO-,R2-R8=H):Example 5: Preparation of Jinggang Hydroxylamine A Valerate (Compound 4) (R 1 =CH 3 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和戊酸(0.204g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到戊酸井冈羟胺A酯0.46g,纯度99.1%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and valeric acid (0.204g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.46 g of Jinggang Hydroxylamine A Valerate with a purity of 99.1%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.76(s,1H),5.44(s,1H),4.65(s,5H),4.17(dd,J=10.6,2.8Hz,1H),4.09–3.86(m,3H),3.70(d,J=4.7Hz,1H),2.28(t,J=7.3Hz,2H),2.03–1.93(m,1H),1.77(d,J=14.1Hz,1H),1.51(dt,J=15.0,7.4Hz,2H),1.38–1.03(m,4H),0.86(t,J=7.3Hz,3H). 1 H NMR (600MHz, DMSO) δ5.76(s, 1H), 5.44(s, 1H), 4.65(s, 5H), 4.17(dd, J=10.6, 2.8Hz, 1H), 4.09–3.86(m ,3H),3.70(d,J=4.7Hz,1H),2.28(t,J=7.3Hz,2H),2.03–1.93(m,1H),1.77(d,J=14.1Hz,1H),1.51 (dt,J=15.0,7.4Hz,2H),1.38–1.03(m,4H),0.86(t,J=7.3Hz,3H).
ESI-MS[M+H]+420.2227,[M+Na]+442.2040ESI-MS[M+H] + 420.2227,[M+Na] + 442.2040
实施例6:己酸井冈羟胺A酯(化合物5)的制备Embodiment 6: the preparation of hexanoic acid Jinggang hydroxylamine A ester (compound 5)
(R1=CH3CH2CH2CH2CH2CO-,R2-R8=H):(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和己酸(0.232g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到己酸井冈羟胺A酯0.45g,纯度98.4%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and hexanoic acid (0.232g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.45 g of hexanoic acid Jinggang hydroxylamine A ester with a purity of 98.4%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.81(dd,J=37.3,3.0Hz,1H),4.68(d,J=13.1Hz,2H),4.35(d,J=13.2Hz,1H),3.96(d,J=17.8Hz,1H),3.69(dd,J=11.3,5.7Hz,1H),3.49(d,J=3.8Hz,31H),3.46–3.17(m,6H),3.11–3.02(m,1H),2.31(dt,J=22.2,7.3Hz,1H),2.15(t,J=7.4Hz,1H),1.74(dd,J=14.1,3.2Hz,1H),1.56–1.36(m,2H),1.36–1.03(m,6H),,0.89(t,J=6.9Hz,3H). 1 H NMR (600MHz, DMSO) δ 5.81 (dd, J = 37.3, 3.0Hz, 1H), 4.68 (d, J = 13.1Hz, 2H), 4.35 (d, J = 13.2Hz, 1H), 3.96 ( d,J=17.8Hz,1H),3.69(dd,J=11.3,5.7Hz,1H),3.49(d,J=3.8Hz,31H),3.46–3.17(m,6H),3.11–3.02(m ,1H),2.31(dt,J=22.2,7.3Hz,1H),2.15(t,J=7.4Hz,1H),1.74(dd,J=14.1,3.2Hz,1H),1.56–1.36(m, 2H),1.36–1.03(m,6H),,0.89(t,J=6.9Hz,3H).
ESI-MS[M+H]+434.2381,[M+Na]+456.2189ESI-MS[M+H] + 434.2381,[M+Na] + 456.2189
实施例7:庚酸井冈羟胺A酯(化合物6)的制备Embodiment 7: the preparation of heptanoic acid Jinggang hydroxylamine A ester (compound 6)
(R1=CH3CH2CH2CH2CH2CH2CO-,R2-R8=H):(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和庚酸(0.260g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到庚酸井冈羟胺A酯0.48g,纯度98.5%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and heptanoic acid (0.260g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with an aqueous ethanol solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.48 g of Jinggang Hydroxylamine A Heptanoate with a purity of 98.5%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.79(dd,J=37.3,3.0Hz,1H),4.62(d,J=13.1Hz,2H),4.33(d,J=13.2Hz,1H),3.94(d,J=17.8Hz,1H),3.71(dd,J=11.3,5.7Hz,1H),3.45(d,J=3.8Hz,31H),3.43–3.17(m,6H),3.11–3.01(m,1H),2.31(dt,J=22.2,7.3Hz,1H),2.18(t,J=7.4Hz,1H),1.71(dd,J=14.1,3.2Hz,1H),1.56–1.38(m,2H),1.36–1.03(m,8H),0.91(t,J=6.9Hz,3H). 1 H NMR (600MHz, DMSO) δ5.79 (dd, J = 37.3, 3.0Hz, 1H), 4.62 (d, J = 13.1Hz, 2H), 4.33 (d, J = 13.2Hz, 1H), 3.94 ( d,J=17.8Hz,1H),3.71(dd,J=11.3,5.7Hz,1H),3.45(d,J=3.8Hz,31H),3.43–3.17(m,6H),3.11–3.01(m ,1H),2.31(dt,J=22.2,7.3Hz,1H),2.18(t,J=7.4Hz,1H),1.71(dd,J=14.1,3.2Hz,1H),1.56–1.38(m, 2H), 1.36–1.03(m, 8H), 0.91(t, J=6.9Hz, 3H).
ESI-MS[M+H]+448.2532,[M+Na]+470.2341ESI-MS[M+H] + 448.2532,[M+Na] + 470.2341
实施例8:辛酸井冈羟胺A酯(化合物7)的制备Embodiment 8: the preparation of caprylic acid Jinggang hydroxylamine A ester (compound 7)
(R1=CH3CH2CH2CH2CH2CH2CH2CO-,R2-R8=H):(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和辛酸(0.288g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到辛酸井冈羟胺A酯0.51g,纯度98.3%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang Hydroxylamine A (1.34g, 4.0mmol) and octanoic acid (0.288g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol was added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.51 g of octanoic acid Jinggang hydroxylamine A ester with a purity of 98.3%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.81(dd,J=37.3,3.0Hz,1H),4.65(d,J=13.1Hz,2H),4.31(d,J=13.2Hz,1H),3.94(d,J=17.8Hz,1H),3.71(dd,J=11.3,5.7Hz,1H),3.45(d,J=3.8Hz,31H),3.40–3.17(m,6H),3.11–3.01(m,1H),2.30(dt,J=22.2,7.3Hz,1H),2.18(t,J=7.4Hz,1H),1.74(dd,J=14.1,3.2Hz,1H),1.56–1.40(m,2H),1.36–1.01(m,10H),0.91(t,J=6.9Hz,3H). 1 H NMR (600MHz, DMSO) δ5.81 (dd, J = 37.3, 3.0Hz, 1H), 4.65 (d, J = 13.1Hz, 2H), 4.31 (d, J = 13.2Hz, 1H), 3.94 ( d,J=17.8Hz,1H),3.71(dd,J=11.3,5.7Hz,1H),3.45(d,J=3.8Hz,31H),3.40–3.17(m,6H),3.11–3.01(m ,1H),2.30(dt,J=22.2,7.3Hz,1H),2.18(t,J=7.4Hz,1H),1.74(dd,J=14.1,3.2Hz,1H),1.56–1.40(m, 2H), 1.36–1.01(m, 10H), 0.91(t, J=6.9Hz, 3H).
ESI-MS[M+H]+462.2686,[M+Na]+484.2492ESI-MS[M+H] + 462.2686,[M+Na] + 484.2492
实施例9:壬酸井冈羟胺A酯(化合物8)的制备Embodiment 9: Preparation of nonanoic acid Jinggang hydroxylamine A ester (compound 8)
(R1=CH3CH2CH2CH2CH2CH2CH2CH2CO-,R2-R8=H):(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和壬酸(0.316g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到壬酸井冈羟胺A酯0.49g,纯度98.9%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang Hydroxylamine A (1.34g, 4.0mmol) and nonanoic acid (0.316g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol was added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.49 g of nonanoic acid Jinggang hydroxylamine A ester with a purity of 98.9%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.79(dd,J=37.3,3.0Hz,1H),4.66(d,J=13.1Hz,2H),4.45(d,J=13.2Hz,1H),3.97(d,J=17.8Hz,1H),3.71(dd,J=11.3,5.7Hz,1H),3.48(d,J=3.8Hz,31H),3.45–3.18(m,6H),3.13–3.04(m,1H),2.29(dt,J=22.2,7.3Hz,1H),2.17(t,J=7.4Hz,1H),1.76(dd,J=14.1,3.2Hz,1H),1.58–1.40(m,2H),1.24(s,10H),1.16–1.00(m,2H),0.86(t,J=6.9Hz,3H). 1 H NMR (600MHz, DMSO) δ5.79 (dd, J=37.3, 3.0Hz, 1H), 4.66 (d, J=13.1Hz, 2H), 4.45 (d, J=13.2Hz, 1H), 3.97( d,J=17.8Hz,1H),3.71(dd,J=11.3,5.7Hz,1H),3.48(d,J=3.8Hz,31H),3.45–3.18(m,6H),3.13–3.04(m ,1H),2.29(dt,J=22.2,7.3Hz,1H),2.17(t,J=7.4Hz,1H),1.76(dd,J=14.1,3.2Hz,1H),1.58–1.40(m, 2H), 1.24(s, 10H), 1.16–1.00(m, 2H), 0.86(t, J=6.9Hz, 3H).
ESI-MS[M+H]+476.2856,[M+Na]+498.2616ESI-MS[M+H] + 476.2856,[M+Na] + 498.2616
实施例10:癸酸井冈羟胺A酯(化合物9)的制备Embodiment 10: the preparation of decanoic acid Jinggang hydroxylamine A ester (compound 9)
(R1=CH3CH2CH2CH2CH2CH2CH2CH2CH2CO-,R2-R8=H):(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和癸酸(0.344g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到癸酸井冈羟胺A酯0.55g,纯度98.4%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and capric acid (0.344g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.55 g of decanoic acid Jinggang hydroxylamine A ester with a purity of 98.4%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.86(dd,J=37.6,3.5Hz,1H),4.62(d,J=13.0Hz,1H),4.48(d,J=13.2Hz,1H),3.92(d,J=18.1Hz,1H),3.65(dd,J=11.0,5.7Hz,1H),3.43(d,J=3.6Hz,1H),3.40–3.13(m,6H),3.11–3.04(m,1H),2.29(dt,J=22.2,7.1Hz,1H),2.17(t,J=7.7Hz,1H),1.81(dd,J=14.5,3.6Hz,1H),1.58–1.42(m,2H),1.24(s,12H),1.16–0.98(m,2H),0.86(t,J=6.5Hz,3H). 1 H NMR (600MHz, DMSO) δ5.86 (dd, J = 37.6, 3.5Hz, 1H), 4.62 (d, J = 13.0Hz, 1H), 4.48 (d, J = 13.2Hz, 1H), 3.92 ( d,J=18.1Hz,1H),3.65(dd,J=11.0,5.7Hz,1H),3.43(d,J=3.6Hz,1H),3.40–3.13(m,6H),3.11–3.04(m ,1H),2.29(dt,J=22.2,7.1Hz,1H),2.17(t,J=7.7Hz,1H),1.81(dd,J=14.5,3.6Hz,1H),1.58–1.42(m, 2H), 1.24(s, 12H), 1.16–0.98(m, 2H), 0.86(t, J=6.5Hz, 3H).
m/z(ESI-MS):[M+H]+490.3008,[M+Na]+512.2746.m/z(ESI-MS):[M + H]+490.3008,[M + Na]+512.2746.
实施例11:正十一烷酸井冈羟胺A酯(化合物10)的制备Embodiment 11: the preparation of n-undecanoic acid Jinggang hydroxylamine A ester (compound 10)
(R1=CH3CH2CH2CH2CH2CH2CH2CH2CH2CH2CO-,R2-R8=H):(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和正十一烷酸(0.372g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到正十一烷酸井冈羟胺A酯0.52g,纯度98.1%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and n-undecanoic acid (0.372g, 2.0mmol) were successively added into a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.52 g of n-undecanoic acid Jinggang Hydroxylamine A ester with a purity of 98.1%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.92(dd,J=37.8,3.7Hz,1H),4.71(d,J=13.5Hz,1H),4.48(d,J=13.7Hz,1H),3.98(d,J=17.2Hz,1H),3.71(dd,J=11.8,5.4Hz,1H),3.46(d,J=3.4Hz,1H),3.42–3.18(m,6H),3.13–3.06(m,1H),2.30(dt,J=22.2,7.2Hz,1H),2.21(t,J=7.4Hz,1H),1.85(dd,J=14.0,3.2Hz,1H),1.56–1.42(m,2H),1.20(s,14H),1.16–0.98(m,2H),0.86(t,J=6.3Hz,3H). 1 H NMR (600MHz, DMSO) δ5.92 (dd, J = 37.8, 3.7Hz, 1H), 4.71 (d, J = 13.5Hz, 1H), 4.48 (d, J = 13.7Hz, 1H), 3.98 ( d,J=17.2Hz,1H),3.71(dd,J=11.8,5.4Hz,1H),3.46(d,J=3.4Hz,1H),3.42–3.18(m,6H),3.13–3.06(m ,1H),2.30(dt,J=22.2,7.2Hz,1H),2.21(t,J=7.4Hz,1H),1.85(dd,J=14.0,3.2Hz,1H),1.56–1.42(m, 2H), 1.20(s, 14H), 1.16–0.98(m, 2H), 0.86(t, J=6.3Hz, 3H).
m/z(ESI-MS):[M+H]+504.3161,[M+Na]+527.1816.m/z(ESI-MS):[M + H]+504.3161,[M + Na]+527.1816.
实施例12:正十二烷酸井冈羟胺A酯(化合物11)的制备:Embodiment 12: the preparation of n-dodecanoic acid Jinggang hydroxylamine A ester (compound 11):
(R1=CH3CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CO-,R2-R8=H)(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H)
井冈羟胺A(1.34g,4.0mmol)和正十二烷酸(0.400g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到正十二烷酸井冈羟胺A酯0.54g,纯度98.2%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and n-dodecanoic acid (0.400g, 2.0mmol) were successively added into a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.54 g of n-dodecanoic acid Jinggang Hydroxylamine A ester with a purity of 98.2%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.95(dd,J=36.5,4.1Hz,1H),4.77(d,J=12.8Hz,1H),4.50(d,J=12.8Hz,1H),3.41(d,J=17.8Hz,1H),3.768(dd,J=11.3,5.7Hz,1H),3.43(d,J=3.8Hz,1H),3.40–3.18(m,6H),3.13–3.06(m,1H),2.32(dt,J=22.2,7.3Hz,1H),2.25(t,J=7.4Hz,1H),1.86(dd,J=14.1,3.2Hz,1H),1.56–1.42(m,2H),1.23(s,12H),1.16–0.92(m,4H),0.81(t,J=6.8Hz,3H). 1 H NMR (600MHz, DMSO) δ 5.95 (dd, J = 36.5, 4.1 Hz, 1H), 4.77 (d, J = 12.8 Hz, 1H), 4.50 (d, J = 12.8 Hz, 1H), 3.41 ( d,J=17.8Hz,1H),3.768(dd,J=11.3,5.7Hz,1H),3.43(d,J=3.8Hz,1H),3.40–3.18(m,6H),3.13–3.06(m ,1H),2.32(dt,J=22.2,7.3Hz,1H),2.25(t,J=7.4Hz,1H),1.86(dd,J=14.1,3.2Hz,1H),1.56–1.42(m, 2H), 1.23(s, 12H), 1.16–0.92(m, 4H), 0.81(t, J=6.8Hz, 3H).
m/z(ESI-MS):[M+H]+518.3310,[M+Na]+540.2876.m/z(ESI-MS):[M + H]+518.3310,[M + Na]+540.2876.
实施例13:正十四烷酸井冈羟胺A酯(化合物12)的制备:Embodiment 13: the preparation of n-tetradecanoic acid Jinggang hydroxylamine A ester (compound 12):
(R1=CH3CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CO-,R2-R8=H)(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H)
井冈羟胺A(1.34g,4.0mmol)和正十三烷酸(0.428g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到正十四烷酸井冈羟胺A酯0.49g,纯度98.6%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and n-tridecanoic acid (0.428g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.49 g of n-tetradecanoic acid Jinggang hydroxylamine A ester with a purity of 98.6%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.93(dd,J=37.3,3.0Hz,1H),4.70(d,J=13.1Hz,1H),4.50(d,J=13.2Hz,1H),3.94(d,J=17.4Hz,1H),3.72(dd,J=11.3,5.7Hz,1H),3.48(d,J=4.2Hz,1H),3.44–3.17(m,6H),3.13–3.02(m,1H),2.31(dt,J=22.2,7.3Hz,1H),2.24(t,J=7.4Hz,1H),1.87(dd,J=14.1,3.2Hz,1H),1.65–1.40(m,2H),1.18(s,12H),1.15–0.81(m,6H),0.74(t,J=6.4Hz,3H). 1 H NMR (600MHz, DMSO) δ5.93 (dd, J = 37.3, 3.0Hz, 1H), 4.70 (d, J = 13.1Hz, 1H), 4.50 (d, J = 13.2Hz, 1H), 3.94 ( d,J=17.4Hz,1H),3.72(dd,J=11.3,5.7Hz,1H),3.48(d,J=4.2Hz,1H),3.44–3.17(m,6H),3.13–3.02(m ,1H),2.31(dt,J=22.2,7.3Hz,1H),2.24(t,J=7.4Hz,1H),1.87(dd,J=14.1,3.2Hz,1H),1.65–1.40(m, 2H), 1.18(s, 12H), 1.15–0.81(m, 6H), 0.74(t, J=6.4Hz, 3H).
m/z(ESI-MS):[M+H]+546.3624,[M+Na]+568.3201m/z(ESI-MS):[M + H]+546.3624,[M + Na]+568.3201
实施例14:正十五烷酸井冈羟胺A酯(化合物13)的制备Embodiment 14: Preparation of n-pentadecanoic acid Jinggang hydroxylamine A ester (compound 13)
(R1=CH3CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CO-,R2-R8=H):(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和正十五烷酸(0.484g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,过滤除去析出的脂肪酸钠,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到正十五烷酸井冈羟胺A酯0.58g,纯度98.4%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and n-pentadecanoic acid (0.484g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH = 7, filter to remove the precipitated sodium fatty acid, and then pass through the macroporous adsorption resin Column separation, the eluent is 0%-55% concentration gradient ethanol aqueous solution for gradient elution, the target liquid is collected, concentrated and dried to obtain 0.58 g of n-pentadecanoic acid Jingganghydroxylamine A ester with a purity of 98.4%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.58(dd,J=6.2,0.6Hz,1H),4.76(d,J=0.9Hz,2H),4.06(dd,J=7.3,0.6Hz,1H),3.75(dd,J=9.2,7.4Hz,1H),3.70(t,J=8.8Hz,1H),3.52(dd,J=12.4,7.1Hz,1H),3.27(dd,J=12.4,7.1Hz,1H),3.19(t,J=8.9Hz,1H),3.13–3.06(m,2H),2.83(dd,J=10.5,8.7Hz,1H),2.61(dd,J=16.9,7.8Hz,1H),2.36(t,J=8.0Hz,2H),2.02(t,J=7.9Hz,1H),1.97(s,1H),1.69(p,J=7.8Hz,2H),1.40–1.29(m,23H),1.21–1.16(m,1H),0.99(t,J=6.4Hz,3H). 1 H NMR (600MHz, DMSO) δ5.58(dd, J=6.2,0.6Hz,1H),4.76(d,J=0.9Hz,2H),4.06(dd,J=7.3,0.6Hz,1H), 3.75(dd, J=9.2, 7.4Hz, 1H), 3.70(t, J=8.8Hz, 1H), 3.52(dd, J=12.4, 7.1Hz, 1H), 3.27(dd, J=12.4, 7.1Hz ,1H),3.19(t,J=8.9Hz,1H),3.13–3.06(m,2H),2.83(dd,J=10.5,8.7Hz,1H),2.61(dd,J=16.9,7.8Hz, 1H), 2.36(t, J=8.0Hz, 2H), 2.02(t, J=7.9Hz, 1H), 1.97(s, 1H), 1.69(p, J=7.8Hz, 2H), 1.40–1.29( m,23H),1.21–1.16(m,1H),0.99(t,J=6.4Hz,3H).
m/z(ESI-MS):[M+H]+560.3833,[M+Na]+582.3432m/z(ESI-MS):[M + H]+560.3833,[M + Na]+582.3432
实施例15:正十六烷酸井冈羟胺A酯(化合物14)的制备Embodiment 15: Preparation of n-hexadecanoic acid Jinggang hydroxylamine A ester (compound 14)
(R1=CH3CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CO-,R2-R8=H):(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和正十六烷酸(0.512g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,过滤除去析出的脂肪酸钠,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到正十六烷酸井冈羟胺A酯0.56g,纯度98.4%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and n-hexadecanoic acid (0.512g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH = 7, filter to remove the precipitated sodium fatty acid, and then pass through the macroporous adsorption resin Column separation, the eluent is 0%-55% ethanol aqueous solution for gradient elution, the target liquid is collected, concentrated and dried to obtain 0.56 g of n-hexadecanoic acid Jingganghydroxylamine A ester with a purity of 98.4%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.58(dd,J=6.2,0.6Hz,1H),4.74(d,J=0.6Hz,2H),4.06(dd,J=4.4,0.9Hz,1H),3.75(dd,J=9.2,4.4Hz,1H),3.55–3.49(m,2H),3.27(dd,J=12.4,7.0Hz,1H),3.22–3.17(m,1H),3.14–3.07(m,2H),2.83(dd,J=10.3,8.1Hz,1H),2.49(dt,J=9.3,7.6Hz,1H),2.32(t,J=8.2Hz,2H),2.19(t,J=8.0Hz,1H),1.71(p,J=8.0Hz,2H),1.51(s,1H),1.41–1.26(m,25H),1.18(t,J=7.9Hz,1H),0.99(t,J=6.4Hz,3H). 1 H NMR (600MHz, DMSO) δ5.58(dd, J=6.2,0.6Hz,1H),4.74(d,J=0.6Hz,2H),4.06(dd,J=4.4,0.9Hz,1H), 3.75(dd,J=9.2,4.4Hz,1H),3.55–3.49(m,2H),3.27(dd,J=12.4,7.0Hz,1H),3.22–3.17(m,1H),3.14–3.07( m,2H),2.83(dd,J=10.3,8.1Hz,1H),2.49(dt,J=9.3,7.6Hz,1H),2.32(t,J=8.2Hz,2H),2.19(t,J =8.0Hz, 1H), 1.71(p, J=8.0Hz, 2H), 1.51(s, 1H), 1.41–1.26(m, 25H), 1.18(t, J=7.9Hz, 1H), 0.99(t ,J=6.4Hz,3H).
m/z(ESI-MS):[M+H]+574.4101,[M+Na]+596.3614m/z(ESI-MS):[M + H]+574.4101,[M + Na]+596.3614
实施例16:正十八烷酸井冈羟胺A酯(化合物15)的制备Embodiment 16: the preparation of n-octadecanoic acid Jinggang hydroxylamine A ester (compound 15)
(R1=CH3CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CO-,R2-R8=H):(R 1 =CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和正十八烷酸(0.568g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡48h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,过滤除去析出的脂肪酸钠,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到正十八烷酸井冈羟胺A酯0.54g,纯度98.6%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and n-octadecanoic acid (0.568g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. Shake at 45°C for 30 minutes. After the reaction system is fully balanced, add lyophilized bacterial cells (1 g), and shake at 45°C for 48 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH = 7, filter to remove the precipitated sodium fatty acid, and then pass through the macroporous adsorption resin Column separation, the eluent is 0%-55% gradient ethanol solution for gradient elution, the target liquid is collected, concentrated and dried to obtain 0.54 g of n-octadecanoic acid Jingganghydroxylamine A ester with a purity of 98.6%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(500MHz,Chloroform)δ5.58(dd,J=6.2,0.6Hz,1H),4.74(d,J=0.9Hz,2H),4.06(dd,J=4.2,0.6Hz,1H),3.75(dd,J=8.9,4.3Hz,1H),3.52(dd,J=12.4,7.6Hz,1H),3.50–3.46(m,1H),3.27(dd,J=12.4,7.6Hz,1H),3.18–3.13(m,1H),3.12–3.07(m,2H),2.83(dd,J=10.4,8.1Hz,1H),2.59(dt,J=9.2,7.7Hz,1H),2.26(dt,J=11.2,8.1Hz,3H),1.70(p,J=8.0Hz,2H),1.43–1.30(m,29H),1.17(s,1H),1.11(t,J=8.0Hz,1H),0.99(t,J=6.5Hz,3H). 1 H NMR (500MHz, Chloroform) δ5.58(dd, J=6.2,0.6Hz,1H),4.74(d,J=0.9Hz,2H),4.06(dd,J=4.2,0.6Hz,1H), 3.75(dd, J=8.9, 4.3Hz, 1H), 3.52(dd, J=12.4, 7.6Hz, 1H), 3.50–3.46(m, 1H), 3.27(dd, J=12.4, 7.6Hz, 1H) ,3.18–3.13(m,1H),3.12–3.07(m,2H),2.83(dd,J=10.4,8.1Hz,1H),2.59(dt,J=9.2,7.7Hz,1H),2.26(dt ,J=11.2,8.1Hz,3H),1.70(p,J=8.0Hz,2H),1.43–1.30(m,29H),1.17(s,1H),1.11(t,J=8.0Hz,1H) ,0.99(t,J=6.5Hz,3H).
m/z(ESI-MS):[M+H]+602.4508,[M+Na]+624.5136m/z(ESI-MS):[M + H]+602.4508,[M + Na]+624.5136
实施例17:7,8-辛烯酸井冈羟胺A酯(化合物16)的制备(R1=CH2=CHCH2CH2CH2CH2CH2CO-,R2-R8=H):Example 17: Preparation of 7,8-octenoic acid jingganghydroxylamine A ester (compound 16) (R 1 =CH 2 =CHCH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和7,8-辛烯酸(0.28g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡72h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到7,8-辛烯酸井冈羟胺A酯0.62g,纯度97.9%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and 7,8-octenoic acid (0.28g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol were added. At 45°C, oscillate on a shaking table for 30 minutes. After the reaction system is fully balanced, add bacterial cell freeze-dried powder (1 g), and shake on a shaking table at 45°C for 72 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with ethanol aqueous solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.62 g of 7,8-octenoic acid Jinggang hydroxylamine A ester with a purity of 97.9%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(600MHz,DMSO)δ5.65(ddt,J=16.3,10.0,6.1Hz,1H),5.58(dd,J=6.2,0.6Hz,1H),5.02–4.97(m,1H),4.97–4.93(m,1H),4.77(d,J=0.9Hz,2H),4.06(d,J=1.3Hz,1H),3.77–3.72(m,2H),3.52(dd,J=12.5,7.5Hz,1H),3.35(s,1H),3.27(dd,J=12.5,7.5Hz,1H),3.22–3.17(m,1H),3.14–3.11(m,1H),3.09(t,J=4.3Hz,1H),2.36(dt,J=9.8,7.9Hz,3H),2.08(t,J=8.0Hz,1H),2.02(dd,J=14.2,7.8Hz,2H),1.74–1.66(m,3H),1.38–1.34(m,4H),1.34–1.30(m,1H),1.15(t,J=7.9Hz,1H). 1 H NMR (600MHz, DMSO) δ5.65 (ddt, J=16.3, 10.0, 6.1Hz, 1H), 5.58 (dd, J=6.2, 0.6Hz, 1H), 5.02–4.97 (m, 1H), 4.97 –4.93(m,1H),4.77(d,J=0.9Hz,2H),4.06(d,J=1.3Hz,1H),3.77–3.72(m,2H),3.52(dd,J=12.5,7.5 Hz,1H),3.35(s,1H),3.27(dd,J=12.5,7.5Hz,1H),3.22–3.17(m,1H),3.14–3.11(m,1H),3.09(t,J= 4.3Hz, 1H), 2.36(dt, J=9.8, 7.9Hz, 3H), 2.08(t, J=8.0Hz, 1H), 2.02(dd, J=14.2, 7.8Hz, 2H), 1.74–1.66( m,3H),1.38–1.34(m,4H),1.34–1.30(m,1H),1.15(t,J=7.9Hz,1H).
m/z(ESI-MS):[M+H]+:460.2506m/z(ESI-MS):[M+H] + :460.2506
实施例18:三氯辛酸井冈羟胺A酯(化合物17)的制备(R1=CCl3CH2CH2CH2CH2CH2CH2CO-,R2-R8=H):Example 18: Preparation of Trichlorooctanoic Acid Hydroxylamine A Ester (Compound 17) (R 1 =CCl 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO-, R 2 -R 8 =H):
井冈羟胺A(1.34g,4.0mmol)和三氯辛酸(0.50g,2.0mmol)依次加入到50mL的锥形烧瓶中,加入环己烷与叔丁醇各10mL。45℃下,摇床振荡30min,反应体系充分平衡后加入菌体冻干粉(1g),45℃下,摇床振荡72h。反应结束后,加入20mL三氯甲烷停止反应,反应液过滤,旋蒸,加入20mL去离子水,然后加入1M氢氧化钠溶液至pH=7,然后通过大孔吸附树脂柱分离,洗脱液为0%-55%浓度梯度的乙醇水溶液进行梯度洗脱,收集目标液,浓缩干燥,得到三氯辛酸井冈羟胺A酯0.49g,纯度98.1%。TLC检测浓缩液,展开剂为正丙醇:水:乙酸=4:1:1,显色剂为碘蒸气与茚三酮溶液。Jinggang hydroxylamine A (1.34g, 4.0mmol) and trichlorooctanoic acid (0.50g, 2.0mmol) were successively added to a 50mL Erlenmeyer flask, and 10mL each of cyclohexane and tert-butanol was added. At 45°C, oscillate on a shaking table for 30 minutes. After the reaction system is fully balanced, add bacterial cell freeze-dried powder (1 g), and shake on a shaking table at 45°C for 72 hours. After the reaction is over, add 20 mL of chloroform to stop the reaction, filter the reaction solution, rotary evaporate, add 20 mL of deionized water, then add 1M sodium hydroxide solution to pH=7, then separate through a macroporous adsorption resin column, and the eluent is Gradient elution was carried out with an aqueous ethanol solution with a concentration gradient of 0%-55%, and the target liquid was collected, concentrated and dried to obtain 0.49 g of triclooctanoic acid Jinggang Hydroxylamine A ester with a purity of 98.1%. The concentrated solution was detected by TLC, the developer was n-propanol: water: acetic acid = 4:1:1, and the color developer was iodine vapor and ninhydrin solution.
1H NMR(500MHz,Chloroform)δ5.58(dd,J=6.2,0.6Hz,1H),4.74(d,J=0.6Hz,2H),4.06(dd,J=2.6,0.6Hz,1H),4.00(dd,J=7.0,3.3Hz,1H),3.74(t,J=3.1Hz,1H),3.52(dd,J=12.4,7.1Hz,1H),3.35(t,J=8.3Hz,1H),3.27(dd,J=12.4,7.1Hz,1H),3.21–3.15(m,1H),3.11–3.06(m,1H),2.82(dd,J=10.3,8.3Hz,1H),2.43(dt,J=9.2,7.7Hz,1H),2.37–2.28(m,4H),1.90(t,J=7.9Hz,1H),1.73(p,J=8.0Hz,2H),1.51(s,1H),1.42–1.32(m,6H),1.31(d,J=4.1Hz,1H),1.24(t,J=7.9Hz,1H). 1 H NMR (500MHz, Chloroform) δ5.58(dd, J=6.2,0.6Hz,1H),4.74(d,J=0.6Hz,2H),4.06(dd,J=2.6,0.6Hz,1H), 4.00(dd, J=7.0, 3.3Hz, 1H), 3.74(t, J=3.1Hz, 1H), 3.52(dd, J=12.4, 7.1Hz, 1H), 3.35(t, J=8.3Hz, 1H ),3.27(dd,J=12.4,7.1Hz,1H),3.21–3.15(m,1H),3.11–3.06(m,1H),2.82(dd,J=10.3,8.3Hz,1H),2.43( dt,J=9.2,7.7Hz,1H),2.37–2.28(m,4H),1.90(t,J=7.9Hz,1H),1.73(p,J=8.0Hz,2H),1.51(s,1H ),1.42–1.32(m,6H),1.31(d,J=4.1Hz,1H),1.24(t,J=7.9Hz,1H).
m/z(ESI-MS):[M+H]+:565.1462m/z(ESI-MS):[M+H] + :565.1462
实施例19:抗菌活性的测定Embodiment 19: Determination of antibacterial activity
采用的测定方法是菌丝生长速率法。具体操作:用直径为6.0mm的打孔器在土豆培养基的边缘取活化好的R.solani菌碟,将菌碟菌丝面朝下,分别接种至含药琼脂培养基平板和对照组培养基平板的正中央,于25℃的恒温培养箱中培养,待对照菌落直径在50mm和80mm之间时(R.solani一般需要36h)利用游标卡尺测量,由数据的平均值计算菌落直径,最终算得抑制率。菌丝生长抑制率计算公式4-1(长度单位:mm)如下:The measurement method used is the mycelial growth rate method. Specific operation: Use a hole puncher with a diameter of 6.0mm to take the activated R. solani bacteria plate on the edge of the potato medium, put the mycelium of the bacteria plate facing down, and inoculate them on the drug-containing agar medium plate and the control group respectively. In the center of the base plate, cultivate in a constant temperature incubator at 25°C. When the diameter of the control colony is between 50mm and 80mm (R.solani generally takes 36h), use a vernier caliper to measure it. Inhibition rate. Mycelium growth inhibition rate calculation formula 4-1 (length unit: mm) is as follows:
实验过程中,先以多个待测试剂稀释到1000μg/mL的浓度得到的抑制率做参照,若抑制率为0则舍弃,相反,若抑制率大于0,则以500μg/mL、250μg/mL、125μg/mL、62.5μg/mL、31.25μg/mL等浓度梯度做抑菌活性测定。During the experiment, first use the inhibition rate obtained by diluting multiple test agents to a concentration of 1000 μg/mL as a reference. If the inhibition rate is 0, discard it. On the contrary, if the inhibition rate is greater than 0, use 500 μg/mL, 250 μg/mL , 125μg/mL, 62.5μg/mL, 31.25μg/mL and other concentration gradients for the determination of antibacterial activity.
药物毒力回归方程和有效中浓度EC50与EC5的计算:以菌丝生长抑制率表示药物对R.solani的毒力。对菌丝生长的抑制率换算成抑制几率值(y),药剂浓度换算成浓度对数(x),按最小二乘法求出药物对R.solani抑制几率值的回归方程决定系数R,根据毒力回归方程分别计算药物对菌丝生长的抑制中浓度EC5和EC50值。Regression equation of drug toxicity and calculation of effective middle concentration EC 50 and EC 5 : The toxicity of the drug to R.solani was expressed by the rate of inhibition of mycelial growth. The inhibition rate of mycelia growth is converted into the inhibition probability value (y), the concentration of the drug is converted into the concentration logarithm (x), and the regression equation determination coefficient R of the drug to the inhibition probability value of R.solani is obtained by the least square method, according to the toxicity The force regression equation was used to calculate the concentration EC 5 and EC 50 values of drugs on the inhibition of hyphae growth.
表1不同药物对R.solani的毒力方程Table 1 Toxicity equation of different drugs to R.solani
从上表可见,该类化合物具有很好的生物活性,其中,部分化合物对水稻纹枯病的抑制作用超过了井冈霉素A,甚至最低作用效果相较于井冈霉素A或井冈羟胺A,低2-3个数量级。因此,该类化合物具有巨大的应用前景和商业价值,有望开发成为替代井冈霉素的新型高效、绿色杀菌剂。It can be seen from the above table that this type of compound has good biological activity. Among them, the inhibitory effect of some compounds on rice sheath blight exceeds that of Jinggangmycin A, and even the lowest effect is compared with Jinggangmycin A or Jinggang Hydroxylamine A. 2-3 orders of magnitude lower. Therefore, this type of compound has great application prospects and commercial value, and is expected to be developed as a new type of high-efficiency and green fungicide to replace Jinggangmycin.
实施例20:井冈羟胺A-叔丁醇饱和溶液的制备Embodiment 20: Preparation of Jinggang hydroxylamine A-tert-butanol saturated solution
90℃油浴锅中,井冈羟胺A(5g)在叔丁醇(300mL)中回流搅拌5h制得井冈羟胺A-叔丁醇饱和溶液。Jinggang hydroxylamine A (5 g) was stirred in tert-butanol (300 mL) for 5 h in an oil bath at 90° C. to prepare a saturated solution of Jinggang hydroxylamine A-tert-butanol.
90℃油浴锅中,井冈羟胺A(5g)在叔丁醇(300mL)中不回流条件下搅拌30h制得井冈羟胺A-叔丁醇饱和溶液。Jinggang hydroxylamine A (5 g) was stirred in tert-butanol (300 mL) in an oil bath at 90°C for 30 h without reflux to prepare a saturated solution of Jinggang hydroxylamine A-tert-butanol.
两种溶液的溶解度如表2所示:The solubility of the two solutions is shown in Table 2:
表2Table 2
实施例21:Example 21:
90℃油浴锅中,井冈羟胺A(5g)在叔丁醇(300mL)中回流搅拌5h制得井冈羟胺A-叔丁醇饱和溶液。将井冈羟胺A-叔丁醇饱和溶液(21mL,0.5mmoL)和十一酸(1.0mmoL,186.33mg)于反应容器中于40℃充分混合,然后加入脂肪酶Lipozyme RMIM(100mg)和已于400℃活化2h的4A°分子筛(1g)在40℃振荡反应,反应30h后取样,加水稀释,过膜,高效液相色谱仪分析;其中,流动相为pH=7.0PBS溶液和甲醇的混合液(其中甲醇的体积分数为3%)。高效液相色谱仪分析结果:井冈羟胺A转化率分别为26.87%。Jinggang hydroxylamine A (5 g) was stirred in tert-butanol (300 mL) for 5 h in an oil bath at 90° C. to prepare a saturated solution of Jinggang hydroxylamine A-tert-butanol. Jinggang hydroxylamine A-tert-butanol saturated solution (21mL, 0.5mmoL) and undecanoic acid (1.0mmoL, 186.33mg) were fully mixed in a reaction vessel at 40°C, then lipase Lipozyme RMIM (100mg) was added and dissolved at 400 4A° molecular sieve (1g) activated for 2h at 40°C was shaken and reacted, sampled after 30h of reaction, diluted with water, passed through a membrane, and analyzed by high performance liquid chromatography; wherein, the mobile phase was a mixture of pH=7.0 PBS solution and methanol ( Wherein the volume fraction of methanol is 3%). Analysis results of high performance liquid chromatography: Jinggang hydroxylamine A conversion rate was 26.87%.
反应液经离心除去分子筛及催化剂,蒸除溶剂,然后加水并用氢氧化钠调节pH值至中性,通过大孔吸附树脂柱(上海华震科技有限公司,HZ-801)分离,以体积浓度为0%-55%的乙醇水溶液为洗脱试剂进行梯度洗脱,收集目标液,浓缩干燥得到产物,产物的1HNMR(600MHz,DMSO)和m/z(ESI-MS)表征表明其与上述化合物10为同一物质,即为十一酸井冈羟胺A酯,产物纯度为98%。The reaction solution was centrifuged to remove the molecular sieve and catalyst, and the solvent was evaporated, then water was added and the pH value was adjusted to neutrality with sodium hydroxide, separated by a macroporous adsorption resin column (Shanghai Huazhen Technology Co., Ltd., HZ-801), and the volume concentration was 0%-55% ethanol aqueous solution was used as the elution reagent for gradient elution, the target liquid was collected, concentrated and dried to obtain the product, and the 1 HNMR (600MHz, DMSO) and m/z (ESI-MS) characterization of the product showed that it was compatible with the above compound 10 is the same substance, that is undecanoic acid Jinggang hydroxylamine A ester, and the product purity is 98%.
实施例22:筛选最适脂肪酶催化十一酸井冈羟胺A的合成Example 22: Screening of the most suitable lipase to catalyze the synthesis of undecanoic acid Jinggang Hydroxylamine A
改变脂肪酶,其他反应步骤同实施例21,所得产物均为十一酸井冈羟胺A酯,其中高效液相色谱仪分析结果如下表所示:Change lipase, other reaction steps are with embodiment 21, and gained product is undecanoic acid Jinggang hydroxylamine A ester, and wherein high performance liquid chromatography analysis result is as shown in the following table:
表3:不同脂肪酶a催化下的井冈羟胺A转化率Table 3: The conversion rate of Jinggang hydroxylamine A catalyzed by different lipase a
a表中所列的脂肪酶均购买于厦门慧嘉生物科技有限公司。The lipases listed in the table a were purchased from Xiamen Huijia Biotechnology Co., Ltd.
结果显示,Lipozyme RMIM的催化效率最高,井冈羟胺A转化率达26.87%。The results showed that Lipozyme RMIM had the highest catalytic efficiency, and the conversion rate of Jinggang hydroxylamine A reached 26.87%.
实施例23:Lipozyme RMIM催化合成十一酸井冈羟胺A的条件优化—反应时间Example 23: Lipozyme RMIM Catalyzed Synthesis of Undecanoic Acid Jinggang Hydroxylamine A Condition Optimization—Reaction Time
将井冈羟胺A-叔丁醇饱和溶液(21mL,0.5mmoL)和十一酸(1.0mmoL,186.33mg)于反应容器中于40℃充分混合,然后加入Lipozyme RMIM(100mg)和已于400℃活化2h的4A°分子筛(1g)在40℃振荡反应,反应过程取样,加水稀释,过膜,高效液相色谱仪分析;其中,流动相为pH=7.0PBS溶液和3%甲醇的混合液。高效液相色谱仪分析结果如表4所示:Jinggang hydroxylamine A-tert-butanol saturated solution (21mL, 0.5mmoL) and undecanoic acid (1.0mmoL, 186.33mg) were thoroughly mixed in a reaction vessel at 40°C, then Lipozyme RMIM (100mg) was added and activated at 400°C The 4A°molecular sieve (1g) was shaken and reacted at 40°C for 2h. During the reaction, samples were taken, diluted with water, passed through a membrane, and analyzed by high-performance liquid chromatography; wherein, the mobile phase was a mixture of pH=7.0 PBS solution and 3% methanol. High performance liquid chromatography analysis result is as shown in table 4:
表4不同反应时间下的井冈羟胺A转化率Jinggang hydroxylamine A transformation rate under the different reaction times of table 4
结果显示,Lipozyme RMIM的最佳催化时间为48小时,井冈羟胺A转化率达26.54%。The results showed that the optimal catalytic time of Lipozyme RMIM was 48 hours, and the conversion rate of Jinggang hydroxylamine A was 26.54%.
实施例24:Lipozyme RMIM催化合成十一酸井冈羟胺A的条件优化—温度Example 24: Lipozyme RMIM Catalyzed Synthesis of Undecanoic Acid Hydroxylamine A Condition Optimization—Temperature
将井冈羟胺A-叔丁醇饱和溶液(21mL,,0.5mmoL)和十一酸(1.0mmoL,186.33mg)于反应容器中(于25℃,30℃,35℃,40℃,45℃,50℃)充分混合,然后加入脂肪酶(100mg)和已于400℃活化2h的4A°分子筛(1g)(在25℃,30℃,35℃,40℃,45℃,50℃)振荡反应,反应48h后取样,加水稀释,过膜,高效液相色谱仪分析;其中,流动相为pH=7.0PBS溶液和3%甲醇的混合液。高效液相色谱仪分析结果如表5所示:Jinggang hydroxylamine A-tert-butanol saturated solution (21mL, 0.5mmoL) and undecanoic acid (1.0mmoL, 186.33mg) were placed in a reaction vessel (at 25°C, 30°C, 35°C, 40°C, 45°C, 50°C ℃) and mix well, then add lipase (100mg) and 4A° molecular sieve (1g) which has been activated at 400℃ for 2h (at 25℃, 30℃, 35℃, 40℃, 45℃, 50℃) and shake the reaction, the reaction After 48 hours, samples were taken, diluted with water, passed through a membrane, and analyzed by high-performance liquid chromatography; wherein, the mobile phase was a mixture of pH=7.0 PBS solution and 3% methanol. High performance liquid chromatography analysis result is as shown in table 5:
表5:不同温度下的井冈羟胺A转化率Table 5: Jinggang hydroxylamine A conversion rate at different temperatures
结果显示,Lipozyme RMIM的最适催化温度为45℃。The results showed that the optimal catalytic temperature of Lipozyme RMIM was 45℃.
实施例25:Lipozyme RMIM催化合成十一酸井冈羟胺A的条件优化—分子筛加量Example 25: Condition optimization for the synthesis of undecanoic acid hydroxyamine A catalyzed by Lipozyme RMIM—molecular sieve dosage
将井冈羟胺A-叔丁醇饱和溶液(21mL,,0.5mmoL)和十一酸(1.0mmoL,186.33mg)于反应容器中于45℃充分混合,然后加入脂肪酶(100mg)和已经400℃活化2小时的4A°分子筛(0g、0.2g、0.4g、0.6g、0.8g、1.0g)在45℃振荡反应,反应48h后取样,加水稀释,过膜,高效液相色谱仪分析;其中,流动相为pH=7.0PBS溶液和3%甲醇的混合液。高效液相色谱仪分析结果如表6所示:Jinggang hydroxylamine A-tert-butanol saturated solution (21mL, 0.5mmoL) and undecanoic acid (1.0mmoL, 186.33mg) were thoroughly mixed in a reaction vessel at 45°C, then lipase (100mg) was added and activated at 400°C 4A ° molecular sieves (0g, 0.2g, 0.4g, 0.6g, 0.8g, 1.0g) were shaken and reacted at 45°C for 2 hours, sampled after 48h of reaction, diluted with water, passed through a membrane, and analyzed by high performance liquid chromatography; wherein, The mobile phase is a mixture of pH=7.0 PBS solution and 3% methanol. High performance liquid chromatography analysis result is as shown in table 6:
表6不同分子筛加量下的井冈羟胺A转化率Table 6 Jinggang hydroxylamine A conversion rate under different molecular sieve additions
结果显示,最适分子筛量为1.2g/mmoL。The results showed that the optimum molecular sieve content was 1.2g/mmoL.
实施例26:Lipozyme RMIM催化合成十一酸井冈羟胺A的条件优化—底物摩尔比Example 26: Condition optimization for the synthesis of undecanoic acid hydroxyamine A catalyzed by Lipozyme RMIM - substrate molar ratio
将井冈羟胺A-叔丁醇饱和溶液(21mL,,0.5mmoL)和十一酸(0.125mmoL,0.167mmoL,0.25mmoL,0.5mmoL,1.0mmoL,1.5mmoL,2.0mmoL)于反应容器中于45℃充分混合,然后加入脂肪酶(100mg)和已于400℃活化2h的4A°分子筛(0.6g)在45℃振荡反应,反应48h后取样,加水稀释,过膜,高效液相色谱仪分析;其中,流动相为pH=7.0PBS溶液和3%甲醇的混合液。高效液相色谱仪分析结果如表7所示:Put Jinggang hydroxylamine A-tert-butanol saturated solution (21mL, 0.5mmoL) and undecanoic acid (0.125mmoL, 0.167mmoL, 0.25mmoL, 0.5mmoL, 1.0mmoL, 1.5mmoL, 2.0mmoL) in a reaction vessel at 45°C Mix well, then add lipase (100mg) and 4A° molecular sieve (0.6g) which has been activated at 400°C for 2h, shake and react at 45°C, take a sample after reacting for 48h, dilute with water, pass through a membrane, and analyze by high performance liquid chromatography; , the mobile phase is a mixture of pH=7.0 PBS solution and 3% methanol. High performance liquid chromatography analysis result is as shown in table 7:
表7不同底物摩尔比下的井冈羟胺A转化率The conversion rate of Jinggang hydroxylamine A under different substrate molar ratios in table 7
结果显示,综合考虑反应的物料及转化率,Lipozyme RMIM催化反应的最适摩尔比为1:3。The results showed that the optimal molar ratio of Lipozyme RMIM catalyzed reaction was 1:3 considering the materials and conversion rate of the reaction.
不同底物摩尔比下得到的反应液的后处理方法同实施例21,所得产物均为十一酸井冈羟胺A酯。The post-treatment method of the reaction solution obtained under different substrate molar ratios is the same as in Example 21, and the obtained products are all undecanoic acid Jinggang Hydroxylamine A esters.
实施例27:Lipozyme RMIM催化合成十一酸井冈羟胺A的条件优化—酶加量Example 27: Condition optimization for the synthesis of undecanoic acid hydroxyamine A catalyzed by Lipozyme RMIM—enzyme dosage
将井冈羟胺A-叔丁醇饱和溶液(21mL,,0.5mmoL)和十一酸(1.5mmoL,279.495mg)于反应容器中于45℃充分混合,然后加入脂肪酶(20mg,40mg,60mg,80mg,100mg,120mg)和已于400℃活化2h的4A°分子筛(0.6g)在45℃振荡反应,反应48h后取样,加水稀释,过膜,高效液相色谱仪分析;其中,流动相为pH=7.0PBS溶液和3%甲醇的混合液。高效液相色谱仪分析结果如表8所示:Jinggang hydroxylamine A-tert-butanol saturated solution (21mL, 0.5mmoL) and undecanoic acid (1.5mmoL, 279.495mg) were thoroughly mixed in a reaction vessel at 45°C, then lipase (20mg, 40mg, 60mg, 80mg , 100mg, 120mg) and 4A° molecular sieve (0.6g) which had been activated at 400°C for 2h were shaken and reacted at 45°C, sampled after 48h of reaction, diluted with water, passed through a membrane, and analyzed by high performance liquid chromatography; wherein, the mobile phase was pH = Mixture of 7.0 PBS solution and 3% methanol. High performance liquid chromatography analysis result is as shown in table 8:
表8不同酶加量下的井冈羟胺A转化率Table 8 The conversion rate of Jinggang hydroxylamine A under different enzyme dosages
结果显示,在反应体系为21mL时,酶的最适加量为80mg,即160g/moL。The results showed that when the reaction system was 21mL, the optimal amount of enzyme added was 80mg, that is, 160g/moL.
综上所述,在井冈羟胺A-叔丁醇饱和溶液中,当使用Lipozyme RMIM作为催化剂,井冈羟胺A与十一酸的摩尔比为1:3,反应温度为45℃,分子筛量为1.2g/mmoL,酶加量为200g/moL时,反应48h井冈羟胺A转化率高达43%。In summary, in Jinggang hydroxylamine A-tert-butanol saturated solution, when using Lipozyme RMIM as catalyst, the molar ratio of Jinggang hydroxylamine A to undecanoic acid is 1:3, the reaction temperature is 45°C, and the amount of molecular sieve is 1.2g /mmoL, when the enzyme dosage was 200g/moL, the conversion rate of Jinggang hydroxylamine A was as high as 43% after 48 hours of reaction.
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910362858.5A CN111850061B (en) | 2019-04-30 | 2019-04-30 | A kind of preparation method of Jinggang hydroxylamine A ester compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910362858.5A CN111850061B (en) | 2019-04-30 | 2019-04-30 | A kind of preparation method of Jinggang hydroxylamine A ester compound |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111850061A CN111850061A (en) | 2020-10-30 |
CN111850061B true CN111850061B (en) | 2022-12-09 |
Family
ID=72965641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910362858.5A Active CN111850061B (en) | 2019-04-30 | 2019-04-30 | A kind of preparation method of Jinggang hydroxylamine A ester compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111850061B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113444003B (en) * | 2021-05-25 | 2022-11-25 | 浙江工业大学 | Validamine hydroxylamine ester A derivative and preparation and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1740332A (en) * | 2005-09-06 | 2006-03-01 | 浙江工业大学 | Preparation of effective mycylamine by microbial cleavage of acarbose and its derivatives |
CN101130562A (en) * | 2007-09-14 | 2008-02-27 | 浙江工业大学 | A kind of preparation method of high-purity Jinggangmycin powder |
CN105002236A (en) * | 2015-05-18 | 2015-10-28 | 浙江工业大学 | Preparation method of high-purity validamycin A |
EP3628320A1 (en) * | 2011-11-11 | 2020-04-01 | Gilead Apollo, LLC | Acc inhibitors and uses thereof |
CN111635328A (en) * | 2019-03-02 | 2020-09-08 | 浙江工业大学 | A kind of ester compound of Jinggang hydroxylamine A and its preparation and antibacterial application |
-
2019
- 2019-04-30 CN CN201910362858.5A patent/CN111850061B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1740332A (en) * | 2005-09-06 | 2006-03-01 | 浙江工业大学 | Preparation of effective mycylamine by microbial cleavage of acarbose and its derivatives |
CN101130562A (en) * | 2007-09-14 | 2008-02-27 | 浙江工业大学 | A kind of preparation method of high-purity Jinggangmycin powder |
EP3628320A1 (en) * | 2011-11-11 | 2020-04-01 | Gilead Apollo, LLC | Acc inhibitors and uses thereof |
CN105002236A (en) * | 2015-05-18 | 2015-10-28 | 浙江工业大学 | Preparation method of high-purity validamycin A |
CN111635328A (en) * | 2019-03-02 | 2020-09-08 | 浙江工业大学 | A kind of ester compound of Jinggang hydroxylamine A and its preparation and antibacterial application |
Non-Patent Citations (4)
Title |
---|
Chemoenzymatic Synthesis of Carbohydrates as Antidiabetic and Anticancer Drugs;Andrés R Alcántara等;《Curr Top Med Chem.》;ingentaconnect;20141231;第14卷(第23期);第2694-2711页 * |
Synthesis of a series of validoxylamine A esters and their biological activities;Yuele Lu等;《Pest Management Science》;Wiley;20211130;第77卷(第11期);第5109-5119页 * |
井冈羟胺 A 酯类衍生物的酶法合成及其生物活性;叶康等;《农药学学报》;CNKI;20210712;第23卷(第4期);第869-876页 * |
井冈羟胺A的衍生及其生物活性研究;郑鹛;《万方学位论文》;万方;20070807;第1-91页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111850061A (en) | 2020-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3111470B2 (en) | Novel polypeptide compound and method for producing the same | |
FI67231B (en) | FRAMEWORK FOR HYPOKOLESTEREMISK FOERENING | |
WO2021047431A1 (en) | Fermentation culture medium and fermentation method capable of increasing yield of a40926 b0 | |
JPH06505472A (en) | Bridged cyclic ketal derivatives | |
CN106866419A (en) | One terpenoid ester compounds and its production and use | |
CN110863021A (en) | Preparation method and application of cytochalasin compound | |
CN106167815A (en) | The Preparation method and use of it dimension streptozotocin derivative | |
Luti et al. | An application of solid state fermentation and elicitation with some microbial cells for the enhancement of prodigiosin production by Serratia marcescens | |
Harris et al. | Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs | |
CN103183666B (en) | Cyclopiazonic acid compound, and preparation and application thereof | |
CN111850061B (en) | A kind of preparation method of Jinggang hydroxylamine A ester compound | |
CN101962401A (en) | Polypeptin and preparation and application thereof | |
CN115894401A (en) | Tetracyclic sesquiterpenoids and their synthetic gene clusters | |
CN104894173B (en) | A kind of preparation method of curcumin derivate | |
CN112795609B (en) | Method for efficiently preparing cyclodepsipeptide, cyclodepsipeptide and application | |
CN103060364B (en) | A recombinant streptomyces lydicus producing natamycin, a construction method and applications thereof | |
CN111411134B (en) | A preparation method for producing purine by fermentation of marine bacillus sp.JIN118 | |
CN104611283B (en) | A kind of recombination streptomyces lydicus and its application | |
CN111635328B (en) | Esterified validoxylamine A and preparation and antibacterial application thereof | |
JPH046189B2 (en) | ||
CN104480134A (en) | High-efficiency biocontrol recombinant streptomyces lydicus as well as construction method and application thereof | |
CN117925747A (en) | Application of Serratia marcescens in the co-production of prodigiosin and diltiazem intermediates | |
WO2020177044A1 (en) | Ester of validoxylamine a, preparation therefor and antimicrobial use thereof | |
CN113817617B (en) | Aphidicolor bacteroides aphidicolor strain for producing mannosylerythritol lipid and application thereof | |
CN115584330A (en) | Nocardiopsis, compound Novofuran and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |